Naquila, Madelyn C.

HRN: 23 06 49  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/18/2023
05/24/2023
IV INFUSION
1.5gm
Q6
Aphthous Stomatitis
Waiting Final Action 
05/19/2023
FLUCONAZOLE 150MG (CAP)
05/19/2023
05/26/2023
PO
1 Cap
2x Per Week
Oral Candidiasis
Waiting Final Action 
05/25/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
05/25/2023
06/01/2023
PO
1/2 Dropper
Q4H Waking Hours
Oral Candidiasis
Waiting Final Action 
05/29/2023
FLUCONAZOLE 50MG (CAP)
05/29/2023
06/26/2023
PO
100mg
OD
Fungi Infection
Waiting Final Action 
05/29/2023
CO-AMOXICLAV 625MG (TAB)
05/29/2023
06/05/2023
PO
625mg
BID
Empiric
Waiting Final Action 
06/02/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/02/2023
06/09/2023
IV
500mg
Q8
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: